Physician profile
Mark R Gorman
NPI 1780680165
$261.80
in general payments reported to CMS, 2019-2025
11 companies · $14.11 in 2025
The $14.11 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.61 · 2022: $64.59 · 2023: $157 · 2025: $14.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $76.93 | 2022-2023 | Cmf |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.44 | 2022-2023 | Jublia |
| Paratek Pharmaceuticals, INC. | $21.64 | 2023 | Nuzyra |
| Tactile Systems Technology INC | $20.81 | 2023 | Entre Plus, Flexitouch Plus |
| Bioventus LLC | $20.02 | 2023 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $19.96 | 2023 | Krystexxa |
| Orthofix Medical, INC. | $16.78 | 2023 | Physio-Stim |
| Medtronic Vascular, INC. | $14.14 | 2019 | |
| Advanced Oxygen Therapy INC. | $14.11 | 2025 | Topical Oxygen Chamber For Extremities |
| Merck Sharp & Dohme LLC | $11.47 | 2019 | |
| Aap Implants INC | $7.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.